Contrast-enhanced MRI for early detection and staging of breast cancer: Do we need it?;Kontrastmittel-MRT der Brust bei Staging und Früherkennung: Wo benötigen wir sie?

Geburtshilfe und Frauenheilkunde

Volumn 70, Issue 3, 2010, Pages 184-193

  Heywang Kobrunner, S H ^a,b   Hacker, A ^a   Sedlacek, S ^a  

^a Referenzzentrum Mammografie   (Germany)

^b Zentrum für Brustdiagnose München   (Germany)

Author keywords

Breast cancer detection; High risk; MRI; Staging

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; COCHRANE LIBRARY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FOLLOW UP; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; MEDLINE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT INFORMATION; PERCUTANEOUS BIOPSY; PRACTICE GUIDELINE; QUALITY CONTROL;

EID: 77949711215     PISSN: 00165751     EISSN: 14388804     Source Type: Journal    
DOI: 10.1055/s-0029-1240922     Document Type: Article

References (68)

1. Heywang S H., Hahn D, Schmidt H et al. MR imaging of the breast using Gd-DTPA. J Comp Ass Tomogr 1986 10 199-204
2. Heywang S H., Hilbertz T, Pruss E et al. Dynamische Kontrastmitteluntersuchungen mit FLASH bei Kernspintomographie der Mamma. Digitale Bilddiagnostik 1988 8 7-13
3. Kaiser W A., Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 1989 170 681-686
4. Flamig D P., Pierce W B., Harms S E. et al. Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast. Work in progress. Radiology 1991 181 757-763
5. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR Imaging on the therapeutic approach. Radiology 1999 213 881-888
6. Orel S G., Schnall M D., Powell C M. et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995 196 115-122
7. Peters N H., Borel Rinkes I C. H. et al. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 2008 246 116-124. Epub 2007 Nov 16
8. Flamm C R., Ziegler K M., Aronson N. Technology Evaluation Center assessment synopsis: use of magnetic resonance imaging to avoid a biopsy in women with suspicious primary breast lesions. J Am Coll Radiol 2005 2 485-487
9. National Institute for Clinical Excellence (NICE) National Collaborating Centre for Primary Care. Familial breast cancer. The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. Partial update. Draft for consultation. May 2006. Available at: http://www.nice.org.uk/download.aspx?o=317667
10. Heywang-Köbrunner S H., Viehweg P, Schmutzler R et al. Magnetresonanztomographie (MRI). Schulz KD, Albert U Stufe 3 Leitlinie. Brustkrebsfrüherkennung in Deutschland. 1. Aktualisierung 2008. München W. Zuckschwerdt Verlag 2008 129-134 ISBN 978-3-8603-931-9[nl]
11. ACR Guidelines and Standards Committee. ACR practice guideline for the performance of contrast-enhanced magnetic resonance imaging (MRI) of the breast. http://www.acr.org/SecondaryMainMenuCategories/quality-safety/guidelines/ breast/mri-breast.aspx
12. Sardanelli F, Giuseppetti G M., Canavese G et al. Indications for breast magnetic resonance imaging. Consensus Document Attualità in Senologia, Florence 2007. Radiol Med 2008 113 1085-1095
13. Sardanelli F, Boetes C, Borisch C et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. EJC, in Druck.
14. AG-Mammadiagnostik der D R. G. Empfehlungen zur MR-Mammographie. (Mitteilungen der DRG). RoeFo 2005 177 474-475
15. Heywang-Köbrunner S H., Sinnatamby R, Schreer I, and consensus group. Inter-disciplinary consensus on the uses and technique of MR-guided vacuum assisted breast biopsy (VAB): Results of a European consensus meeting. EJR 2009 72 289-294. Epub 2008 Aug 23
16. Perlet C, Heywang-Köbrunner S H., Heinig A et al. Magnetic resonance-guided, vacuum-assisted breast biopsy: results from a European multicenter study of 538 lesions. Cancer 2006 106 982-990
17. Bluemke D A., Gatsonis C A., Chen M H. et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 2004 292 2735-2742
18. Heywang-Köbrunner S H., Bick U, Bradley W G. et al. International investigation of breast MRI: results of a multicenter study (11 sites) concerning diagnostic parameters of contrast-enhanced MRI based on 519 histopathologically correlated lesions. European Radiology 2001 11 531-546
19. Heywang-Köbrunner S H., Viehweg P, Fischer U. Qualitä tssicherung Magnetresonanztomographie. Schulz KD, Albert U Stufe 3 Leitlinie. Brustkrebsfrüherkennung in Deutschland. 1. Aktualisierung 2008. München W. Zuckschwerdt Verlag 2008 171-180 ISBN 978-3-8603-931-9[nl]
20. Kuhl C K. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007 244 356-378
21. Tilanus-Linthorst M M., Obdeijn I M. et al. BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials. Clin Cancer Res 2007 13 7357-7362
22. Causer P A., Jong R A., Warner E et al. Breast cancers detected with imaging screening in the BRCA population: emphasis on MR imaging with histopathologic correlation. Radiographics 2007 Suppl.1 165-182
23. Schrading S, Kuhl C K. Mammographic, US, and MR imaging phenotypes of familial breast cancer. Radiology 2008 246 58-70
24. Warner E, Plewes D B., Hill K A. et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004 292 1317-1325
25. Kriege M, Brekelmans C T., Boetes C et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004 351 427-437
26. Kuhl C K., Schrading S, Leutner C C. et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005 23 8469-8476
27. Leach M O., Boggis C R., Dixon A K. et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005 365 1769-1778
28. Lehman C D., Blume J D., Weatherall P et al, International Breast MRI Consortium Working Group. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005 103 1898-1905
29. Hagen A I., Kvistad K A., Maehle L et al. Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. Breast 2007 16 367-374
30. Riedl C C., Ponhold L, Flory D et al. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clin Cancer Res 2007 13 6144-6152
31. Sardanelli F, Podo F, D'Agnolo G et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 2007 242 698-715
32. Sardanelli F, Podo F. Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection? Eur Radiol 2007 17 873-887
33. Lord S J., Lei W, Craft P et al. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 2007 43 1905-1917
34. Warner E, Messersmith H, Causer P et al. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 2008 148 671-679
35. Heywang-Köbrunner S H., Schreer I, Heindel W et al. Bildgebung für die Brustkrebsfrüherkennung. Dt Ärzteblatt 2008 105 541-547
36. Hoogerbrugge N, Kamm Y J., Bult P et al. The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited. Ann Oncol 2008 19 655-659. Epub 2007 Dec 19
37. Brewer N T., Salz T, Lillie S E. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med 2007 146 502-510
38. Perry N, Broeders M, De Wolf C et al, eds. European guidelines for quality assurance in mammography screening. 4th ed. Luxembourg Office for Official Publications of the European Communities 2006
39. Schmutzler R K., Rhiem K, Breuer P et al. Outcome of a structured surveillance programme in women with a familial predisposition for breast cancer. Eur J Cancer Prev 2006 15 483-489
40. Kriege M, Brekelmans C T., Boetes C et al. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Cancer 2006 106 2318-2326
41. Heyes G J., Mill A J., Charles M W. Mammography-oncogenecity at low doses. J Radiol Prot 2009 29 (2A) A123-A132. Epub 2009 May 19
42. Schmutzler R, Schlegelberger B, Meindl A et al. Hereditäre Brusterkrankung. Schulz KD, Albert U Stufe 3 Leitlinie. Brustkrebsfrü herkennung in Deutschland. 1. Aktualisierung 2008. München W. Zuckschwerdt Verlag 2008 56-61 ISBN 978-3-8603-931-9[nl]
43. Saslow D, Boetes C, Burke W et al, for the American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007 57 75-89
44. Heywang-Köbrunner S H., Möhrling D, Nährig J. The role of MRI before breast conservation. Sem Breast Dis 2007 10 137-144
45. Bluemke D A., Gatsonis C A., Chen M H. et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 2004 292 2735-2742
46. Schnall M D., Blume J, Bluemke D A. et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC6883. J Surg Oncol 2005 92 32-38
47. Sardanelli F, Giuseppetti G M., Panizza P et al. Italian trial for breast MR in multifocal/multicentric cancer. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breast using the whole breast pathologic examination as a gold standard. AJR 2004 183 1149-1157
48. Lehman C D., Gatsonis C, Kuhl C K. et al, ACRIN Trial 6667 Investigators Group. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007 356 1295-1303
49. Berg W A., Gutierrez L, NessAiver M S. et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004 233 830-849
50. Ghai S, Muradali D, Bukhanov K et al. Nonenhancing breast malignancies on MRI: sonographic and pathologic correlation. AJR Am J Roentgenol 2005 185 481-487
51. Hlawatsch A, Teifke A, Schmidt M et al. Preoperative assessment of breast cancer: sonography versus MR imaging. AJR Am J Roentgenol 2002 179 1493-1501
52. Hofvind S, Geller B, Skaane P. Mammographic features and histopathological findings of interval breast cancers. Acta Radiol 2008 49 975-981
53. Schouten van der Velden A P., Boetes C, Bult P et al. The Value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg 2006 192 172-178
54. Van Goethem M, Schelfout K et al. MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component. Eur J Radiol 2007 62 273-282
55. Kim do Y, Moon W K., Cho N et al. MRI of the breast for the detection and assessment of the size of ductal carcinoma in situ. Korean J Radiol 2007 8 32-39
56. Houssami N, Ciatto S, Macaskill P et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008 26 3248-3258
57. Hill-Kayser C E., Harris E E., Hwang W T. et al. Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation. Int J Radiat Oncol Biol Phys 2006 66 1313-1319
58. Katipamula R, Degnim A C., Hoskin T et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 2009 27 4082-4088. Epub 2009 Jul 27
59. Pengel K E., Loo C E., Teertstra H J. et al. The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Res Treat 2009 116 161-169
60. Turnbull L, Brown S, Olivier C et al, on behalf of the COMICE Trial Group. Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). Health Technol Assess 2010 14 1-182
61. Fischer U, Zachariae O, Baum F et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 2004 14 1725-1731
62. Solin L J., Orel S G., Hwang W T. et al. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008 26 386-391
63. Peters N H., van den Bosch M A., Peeters P H. et al. Breast magnetic resonance imaging in early-stage breast cancer: is there really no value? J Clin Oncol 2008 26 3465-3466
64. Peters N H., Borel Rinkes I H., Mali W P. et al. Breast MRI in nonpalpable breast lesions: a randomized trial with diagnostic and therapeutic outcome MONET-study. Trials 2007 8 40
65. Deurloo E E., Klein Zeggelink W F., Teertstra H J. et al. Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients. Eur Radiol 2006 16 692-701. Epub 2005 Nov 19
66. Calderon-Margalit R, Paltiel O. Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature. Int J Cancer 2004 112 357-364
67. Rebbeck T R., Kauff N D., Domchek S M. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 2009 101 80-87. Epub 2009 Jan 13
68. Al-Hallaq H A., Mell L K., Bradley J A. et al. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer 2008 113 2408-2414